Info   Email Video to Friends   Receive Emails for Similar Videos   Repeat and Loop Video   Link to Video   Create Short URL  Publish Text About This Video   Share on Facebook, Twitter, and more   See Recommended Videos For You

  Emerging Adjuvant and Neoadjuvant Options for Melanoma   Neoadjuvant Therapy in Locally Advanced Pancreatic Cancer   Immunotherapy for Operable NSCLC   Metastatic Melanoma: Clinical Pearls From the Experts   The promise and potential dangers of gene therapy | Tomorrow Today - Interview   Novel Targeted Therapies for Metastatic Melanoma   The Potential for Adjuvant Immunotherapy for NSCLC   FDA Activity for Nivolumab, T-VEC in Melanoma, New Lung Cancer Findings, MDS Findings, and More   Dr. Holmes on Neoadjuvant Endocrine Therapy in Breast Cancer   Role of Maintenance Therapy in Mantle Cell Lymphoma   Dr. Ellis on Neoadjuvant Endocrine Therapy for Breast Cancer   Neoadjuvant Trials in High-risk Melanoma   Dr. Tolaney on Neoadjuvant HER2-Directed Therapy   Dr. Ascierto on Triplet of Encorafenib, Binimetinib, and Ribociclib in Melanoma   Unresectable Melanoma—Targeted or Immunotherapy?   Treatment for Early-Stage ER+ Breast Cancer   Ongoing Neoadjuvant Clinical Trials in Pancreatic Cancer   Choosing the Right Therapy for Melanoma   Adjuvant Treatment Selection in High-Risk Melanoma   Role of Lapatinib in HER2-Positive Breast Cancer   Dr. Tolaney on the Neoadjuvant Therapy for HER2-Positive Breast Cancer   Recent Data in the Adjuvant Setting of RCC   Radiofrequency Ablation and Curative Intent in HCC   T-VEC Data in the Neoadjuvant Setting in Melanoma   Adjuvant Therapy for Stage III Melanoma   Adjuvant Therapy Options in Advanced Melanoma   Neoadjuvant Chemotherapy and Ovarian Cancer   Mutation Testing to Guide ALK TKI Selection in NSCLC   Dr. Hudis on Neoadjuvant Treatment of HER2-Positive Breast Cancer   Managing Gastrointestinal Toxicities in Melanoma   Melanoma: BRAF/MEK Targeted Therapy   Monotherapy Versus Combination Therapy Approaches in Melanoma   FDA Approvals in NSCLC, Bladder Cancer, and Breast Cancer, and Death in CAR T-cell Therapy Trial   Radiation Therapy and ADT in CRPC   BRAF-Mutant Melanoma: Frontline Decisions   Imaging and SLN Biopsy for Patients With Melanoma   Lymph Node Management in Melanoma   The Role of Maintenance Therapy in CLL   Docetaxel in Metastatic Prostate Cancer   Neoadjuvant/Adjuvant Approaches in Colorectal Cancer   Dr. Yee on Neoadjuvant Pertuzumab in HER2-Positive Breast Cancer   Dr. Tripathy on Neoadjuvant Treatment Strategies in HER2+ Breast Cancer   Dr. Berman on Evolving Role of Surgery in Melanoma   Dual Targeted or Immunotherapy for BRAF-Mutant Melanoma   NDA Withdrawn in Melanoma, Promising Phase III Results in Breast Cancer and Ovarian Cancer, and More   Adjuvant Therapy for Patients with Melanoma   Dr. Chagpar on Novel Agents for Neoadjuvant TNBC Treatment   Dr. Kumar on Potential of CAR T-Cell Therapy in Multiple Myeloma   Scientists Use Diabetic Drug To Treat Melanoma   Dual-Targeted Therapy for BRAF-Mutant Melanoma   Long-Term Results for Immunotherapy in Melanoma   Melanoma: Speed and Durability of Therapeutic Response   Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors   Dr. Daud on the Combinations of Immunotherapy for Melanoma   Systemic Therapy with T-VEC in Advanced Melanoma   Your Skin Is In Tanning Is Out Pledge | Connecting Point | Feb. 3, 2014   IDO Inhibitors in Metastatic Melanoma   Dr. Siefker-Radtke on FDA Approval of Frontline Atezolizumab in Bladder Cancer   Dr. Hurvitz on Neoadjuvant Therapy for HER2+ Breast Cancer   Monoclonal Antibody Therapy in Myeloma   New Drug Proves Effective For Renal Cell Cancer Patients   Patient Selection in Melanoma: Immunotherapy vs Targeted Therapy   Radiation Therapy and Abscopal Effect in Melanoma Treatment   The Healing Power of Music   CART-T Cell Therapy in Lung Cancer   Applying Immunotherapy Learnings in Melanoma to Lung Cancer   Recommendations for Resectability in Melanoma   Treatment Approaches to Resectable Melanoma   Personalized Approaches to Head and Neck Cancer Therapy   Glioblastoma: The Potential Role of Immunotherapy   Gene Therapy & CRISPR Cas 9 [PPMD's 2016 Connect Conference]   Skin Cancer Awareness | Connecting Point | Jan. 21, 2015   The Potential for IO Use as Maintenance Therapy in NSCLC   Melanoma | Connecting Point | Feb. 8, 2016   Selective Internal Radiation Therapy in Colorectal Cancer

  Please consider supporting this site by Clicking Here and Bookmarking whenever you search and shop Amazon. It costs you nothing but it supports us and gives us credit and we appreciate it greatly.